Developing new contraceptive methods for women, especially those who are obese.
Official title: CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM – CORE FUNCTION ACTIVITIES FOR SITES OF FEMALE CONTRACEPTIVE STUDIES - MAGEE
Funded at Magee-Women's Res Inst and Foundation · NIH-11166252 · Data updated 2026-11-12
This study is working on new birth control methods that are safe and effective, especially for women who are obese, to help prevent unintended pregnancies while keeping health risks low.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Magee-Women's Res Inst and Foundation NIH-funded |
| Lab location | 1 site (Pittsburgh, UNITED STATES) |
| Project start | August 1, 2020 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $15,432 |
| NIH project number | 75N94020D00018-P00005-759402000001-1 |
| Project ID | NIH-11166252 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include women seeking effective contraception, especially those who are obese or have medical conditions that make current contraceptive methods unsuitable.
✕Less likely to help
Patients who are not seeking contraception or who do not have any medical conditions that contraindicate current contraceptive methods may not benefit from this research.
What this research studies
This research focuses on creating new contraceptive methods that effectively prevent unintended pregnancies while minimizing health risks, particularly for obese women who may face increased risks with current contraceptive options. The Contraceptive Clinical Trials Network (CCTN) is dedicated to developing and testing protocols for these new contraceptive agents through clinical trials. By involving women in the research process, the goal is to ensure that the contraceptives developed are both safe and effective for diverse populations.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective contraceptive options for women, particularly those at higher risk due to obesity.
How similar studies have gone: Previous research has shown promise in developing new contraceptive methods, but this specific approach targeting obese women is relatively novel.
Where this research is happening
-
Magee-Women's Res Inst and Foundation
Pittsburgh, United States Active
Researchers
- Principal investigator: Chen, M.d., Mph, Beatrice — Magee-Women's Res Inst and Foundation
- Study coordinator: Chen, M.d., Mph, Beatrice
Related research
Other NIH-funded projects on the same topics.
-
An integrated mobile health program to reduce SAVA and mental health problems among female sex workers in Kenya
A new mobile health program aims to help female sex workers in Kenya avoid substance abuse, violence, HIV, and depression by delivering group therapy, online resources, and a peer discussion space.
-
HIV in Women: How the virus hides and the immune system changes across life stages
This project looks at how HIV behaves differently in people from puberty through menopause, focusing on how hormones like estrogen may affect HIV persistence and immune responses.
-
Mobile health support to boost PrEP and contraception use among young women in Zambia
A mobile health program helps female university students in Zambia learn about and access HIV prevention and contraception.
-
Computational modeling of female hormone balance and drug responses
A new computational model uses patient-like data to predict how metabolic drugs will work in women across their hormonal cycles and different reproductive stages.
-
How PrEP Drugs Affect HIV Risk in Women and Reproductive Health
This project looks at how PrEP medicines work for women, and whether they influence pregnancy-related processes in the uterus.
-
How female eggs throw away most chromosomes during meiosis
A scientist at UC Davis is studying why only a quarter of chromosomes go into the egg during female reproductive cell division and how errors in this process can cause miscarriage or birth defects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.